Ani Pharmaceuticals (ANIP) Construction in Progress (2012 - 2013)

Ani Pharmaceuticals (ANIP) reported Construction in Progress of $197948.0 for Q3 2013, up 12.29% sequentially from $176276.0 in Q2 2013.

Ani Pharmaceuticals (ANIP) Construction in Progress (2012 - 2013) Analysis & Trends

Ani Pharmaceuticals (ANIP) has 2 years of Construction in Progress data on file, last reported at $197948.0 in Q3 2013.

For the quarter ending Q3 2013, Construction in Progress changed N/A year-over-year to $197948.0; the trailing twelve-month figure through Sep 2013 stood at $197948.0 (changed N/A YoY), and the FY2012 full-year result was $208069.0, changed N/A from the prior year.
Construction in Progress climbed to $197948.0 in Q3 2013, from $176276.0 in the prior quarter.
In the past five years, Construction in Progress ranged from a high of $208069.0 in Q4 2012 to a low of $176276.0 in Q2 2013.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Construction in Progress (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Ani Pharmaceuticals	1.64 Bn	1.33 Bn	143.88 Mn	-

Download Data